ArticleTissue barriers2026

Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab therapy in pancreatic ductal adenocarcinoma.

Daisuke Kyuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.